ISTA Pharmaceuticals to Present at Southern California Investor Conference and Stifel Nicolaus Annual Healthcare Conference
(firmenpresse) - IRVINE, CA -- (Marketwire) -- 08/18/11 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced its executives will present at two conferences in August and September. Both conference presentations will be webcast and will be available at .
Monday, August 29, 2011 at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time)
ISTA's Chief Financial Officer and Vice President Corporate Development Lauren Silvernail will make a formal presentation on the marketed products, pipeline and corporate strategy.
Wednesday, September 7, 2011 at 2:40 p.m. Eastern Time
ISTA's President and Chief Executive Officer Vicente Anido, Jr., Ph.D., will conduct a fireside chat with Stifel analyst Annabel Samimy on the company's competitive position and corporate outlook, after which he will also respond to questions from the on-site audience.
To access the live audio broadcast of the presentations, or the subsequent archived recording, log onto . Please connect to the website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.
ISTA Pharmaceuticals, Inc. is a fast growing and the fourth largest branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The Company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies. Headquartered in Irvine, California, ISTA generated revenues of $156.5 million in 2010. For additional information about ISTA, please visit the corporate website at .
Contacts
Investor Relations Contacts at ISTA Pharmaceuticals, Inc.:
Lauren Silvernail
949-788-5302
Jeanie Herbert
949-789-3159
Media and Additional Investor Relations Contacts at Burns McClellan:
Justin Jackson
(Media)
212-213-0006
Juliane Snowden
(Investor Relations)
212-213-0006
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 18.08.2011 - 11:30 Uhr
Sprache: Deutsch
News-ID 47813
Anzahl Zeichen: 0
contact information:
Town:
IRVINE, CA
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 209 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ISTA Pharmaceuticals to Present at Southern California Investor Conference and Stifel Nicolaus Annual Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
ISTA Pharmaceuticals (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
